TEMPUS CAPITAL INC. Logo
CA88024G1019
A2PE0F
TEMP.CN

TEMPUS CAPITAL INC.

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Tempus AI secures $1.1 billion in data contracts, shares rally

    Tempus AI said it signed $1.1 billion in sealed data contracts with 70 customers in 2025, including major life-sciences firms such as AstraZeneca, Pfizer, Merck and Abbvie. The company reported revenue retention around 126% and called 2025 a record year for its Data and Applications business. Shares rose as much as 15% intraday and closed up 4.51% at $69.26. Tempus AI plans to finalize and report full 2025 financial results on an earnings call in February 2026. » More on finance.yahoo.com


  • Tempus AI raises FY25 guidance, cites FDA clearance and Paige acquisition as growth drivers

    Tempus AI guided FY25 revenue to $1.25–$1.26 billion (about 81% YoY) and expects roughly $1.55 billion in FY26 revenue, valuing the company at ~9.16x 2026 sales. Recent catalysts include FDA clearance for its xR IVD product and the $81 million acquisition of Paige, which expand addressable markets and AI pathology capabilities. Analysts note strong revenue visibility and execution, while valuation appears supported by forward growth despite a trailing P/E around 41.5 and elevated share performance since April. » More on finance.yahoo.com


  • Tempus AI reaches all-time high of $98.14

    Tempus AI stock climbed to an all-time high of $98.14, bringing market capitalization to about $16.16 billion. Analyst price targets range from $60 to $100; Guggenheim raised its target to $95 and H.C. Wainwright to $98. Tempus recorded revenue growth of 59.84% over the last twelve months and a 1-year performance of +96.54%. The company received FDA 510(k) clearance for the RNA-based diagnostic Tempus xR IVD and expanded its CARE program for breast cancer screening. » More on de.investing.com


  • ARK Invest increases stake in AMD and divests heavily from Tempus AI

    Cathie Wood’s ARK ETFs bought 25,899 shares of Advanced Micro Devices through ARKF on September 16, worth about $4.17 million. At the same time, a total of 167,598 shares of Tempus AI were sold via ARKK and ARKG for roughly $14.27 million, part of an ongoing reallocation toward selected technology and biotech names. » More on de.investing.com


  • Cathie Woods' ARK ETFs sell Tempus AI and buy Arcturus

    In the trading session on September 15, 2025, Cathie Woods' ARK ETFs adjusted their portfolios: via ARKG, 7,270 shares of Tempus AI were sold for $627,982, while 27,408 shares of Arcturus were purchased for $474,706. At the same time, ARK made buys in Bullish, eToro, Figma and Toast and sales of Kratos, Rocket Lab and Shopify. The transactions point to a strategic reshuffle within the fund's biotechnology and AI positions. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2023, TEMPUS CAPITAL INC. has already paid €0.034 in dividends. The last payout was in August 2023.

Financials

In the last quarter, TEMPUS CAPITAL INC. had revenue of €73.2k and net profit of -€34.56k
(EUR) June 2026
YoY
Revenue 73.2k 2.72%
Gross profit 36.96k 2.92%
Net profit -34.56k 11.85%
EBITDA 2.21k 243.99%

Fundamentals

Metric Value
Market capitalization
€2.81m
Number of shares
30.48m
52-week high/low
€0.0954 - €0.0254
Dividends No
Beta
-0.04
P/E ratio
-17.26
PEG ratio
8.68
P/B ratio
2.62
P/S ratio
8.96

Company profile

Tempus Capital Inc. operates as a real estate operating company in Canada. The company's real estate portfolio includes four properties comprising a commercial plaza, one commercial property, and two mixed commercial/residential properties in Ontario. Tempus Capital Inc. was incorporated in 2011 and is based in Burlington, Canada.

Name
TEMPUS CAPITAL INC.
CEO
Russell Tanz
Headquarters Burlington, on
Canada
Website
Industry
Machinery
IPO
28/02/2019

Ticker symbols

Exchange Symbol
Cnq
TEMP.CN
🍪

Parqet  uses cookies. Learn more